New Results
Development of Nanobodies as first-in-class inhibitors for the NEDP1 deNEDDylating enzyme
Naima Abidi, Helene Trauchessec, Gholamreza Hassanzadeh-Ghassabeh, Martine Pugniere, Serge Muyldermans, View ORCID ProfileDimitris P. Xirodimas
doi: https://doi.org/10.1101/2020.03.20.999326
Naima Abidi
1CRBM, CNRS, University of Montpellier, UMR5237, Montpellier, Cedex 5, France
Helene Trauchessec
1CRBM, CNRS, University of Montpellier, UMR5237, Montpellier, Cedex 5, France
Gholamreza Hassanzadeh-Ghassabeh
2VIB Nanobody Service Facility, Vrije Universiteit Brussel, Pleinlaan2, 1050, Brussels Belgium
Martine Pugniere
3IRCM, Inserm, University of Montpellier, ICM, Montpellier, Cedex 5, France
Serge Muyldermans
4Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan2, 1050, Brussels Belgium
Dimitris P. Xirodimas
1CRBM, CNRS, University of Montpellier, UMR5237, Montpellier, Cedex 5, France
Article usage
Posted March 23, 2020.
Development of Nanobodies as first-in-class inhibitors for the NEDP1 deNEDDylating enzyme
Naima Abidi, Helene Trauchessec, Gholamreza Hassanzadeh-Ghassabeh, Martine Pugniere, Serge Muyldermans, Dimitris P. Xirodimas
bioRxiv 2020.03.20.999326; doi: https://doi.org/10.1101/2020.03.20.999326
Subject Area
Subject Areas
- Biochemistry (11744)
- Bioengineering (8751)
- Bioinformatics (29193)
- Biophysics (14968)
- Cancer Biology (12094)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18303)
- Genetics (12244)
- Genomics (16801)
- Immunology (11866)
- Microbiology (28082)
- Molecular Biology (11592)
- Neuroscience (60959)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)